Liuchunyang Yu

591 total citations
21 papers, 369 citations indexed

About

Liuchunyang Yu is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Liuchunyang Yu has authored 21 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Immunology and 4 papers in Oncology. Recurrent topics in Liuchunyang Yu's work include Extracellular vesicles in disease (5 papers), Natural Compounds in Disease Treatment (4 papers) and Immunotherapy and Immune Responses (3 papers). Liuchunyang Yu is often cited by papers focused on Extracellular vesicles in disease (5 papers), Natural Compounds in Disease Treatment (4 papers) and Immunotherapy and Immune Responses (3 papers). Liuchunyang Yu collaborates with scholars based in China, Hong Kong and United States. Liuchunyang Yu's co-authors include Yuanyan Liu, Cheng Lü, Xinyi Luo, Zhenglai Hua, Aiping Lü, Zhengjia Zhang, Ting Zhao, Yurong Song, Ming Li and Yang Li and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Chemical Engineering Journal.

In The Last Decade

Liuchunyang Yu

18 papers receiving 366 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liuchunyang Yu China 12 160 73 62 59 52 21 369
Jinhai Tang China 13 213 1.3× 211 2.9× 72 1.2× 40 0.7× 27 0.5× 24 476
Jingjing Gong China 13 240 1.5× 55 0.8× 102 1.6× 43 0.7× 55 1.1× 28 476
Yi‐An Cheng Taiwan 11 237 1.5× 114 1.6× 50 0.8× 62 1.1× 43 0.8× 17 413
Fatemeh Rezaei‐Tazangi Iran 12 277 1.7× 121 1.7× 129 2.1× 38 0.6× 72 1.4× 55 572
Małgorzata Krawczyk Poland 13 128 0.8× 110 1.5× 28 0.5× 49 0.8× 71 1.4× 54 467
Shibo Ying China 16 230 1.4× 63 0.9× 111 1.8× 36 0.6× 73 1.4× 35 549
Jiagang Liu China 12 206 1.3× 87 1.2× 25 0.4× 53 0.9× 29 0.6× 46 520
Heng Zheng United States 10 243 1.5× 116 1.6× 98 1.6× 51 0.9× 105 2.0× 14 535
Ying Shen China 6 197 1.2× 58 0.8× 67 1.1× 57 1.0× 36 0.7× 10 398
Dawei Li China 13 247 1.5× 95 1.3× 69 1.1× 46 0.8× 35 0.7× 42 528

Countries citing papers authored by Liuchunyang Yu

Since Specialization
Citations

This map shows the geographic impact of Liuchunyang Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liuchunyang Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liuchunyang Yu more than expected).

Fields of papers citing papers by Liuchunyang Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liuchunyang Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liuchunyang Yu. The network helps show where Liuchunyang Yu may publish in the future.

Co-authorship network of co-authors of Liuchunyang Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Liuchunyang Yu. A scholar is included among the top collaborators of Liuchunyang Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liuchunyang Yu. Liuchunyang Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Liuchunyang, et al.. (2026). Insulin resistance: mechanisms and therapeutic interventions. Molecular Biomedicine. 7(1). 12–12.
2.
Hua, Zhenglai, Liuchunyang Yu, Meng Tian, et al.. (2025). Liver-targeting exosomes loaded naringenin ameliorate metabolic dysfunction-associated steatotic liver disease through ubiquitin-proteasome system initiated lipophagy. Chemical Engineering Journal. 523. 168040–168040.
3.
Yang, Li, Xiaoxia Xue, Liuchunyang Yu, et al.. (2025). Recombinant high-density lipoprotein targeted delivery of celastrol to promote foam cells lipophagy against early atherosclerosis. Journal of Nanobiotechnology. 23(1). 237–237. 3 indexed citations
4.
5.
Yu, Liuchunyang, Zhengjia Zhang, Meng Tian, et al.. (2025). Reinforced immunotherapy of M1 macrophage-derived exosomes with CEL on TNBC via regulating macrophage functions. Journal of Advanced Research. 82. 1163–1178. 1 indexed citations
6.
Tian, Meng, Xiaoyu Li, Liuchunyang Yu, et al.. (2025). Glycosylation as an intricate post-translational modification process takes part in glycoproteins related immunity. Cell Communication and Signaling. 23(1). 214–214. 4 indexed citations
7.
Yu, Liuchunyang, et al.. (2024). A promising anti-tumor targeting on ERMMDs mediated abnormal lipid metabolism in tumor cells. Cell Death and Disease. 15(8). 562–562. 1 indexed citations
8.
Zhang, Zhengjia, Xinyi Luo, Xiaoxia Xue, et al.. (2024). Engineered Exosomes Carrying miR-588 for Treatment of Triple Negative Breast Cancer Through Remodeling the Immunosuppressive Microenvironment. International Journal of Nanomedicine. Volume 19. 743–758. 17 indexed citations
9.
Xue, Xiaoxia, Liuchunyang Yu, Meng Tian, et al.. (2024). An exosomal strategy for targeting cancer-associated fibroblasts mediated tumors desmoplastic microenvironments. Journal of Nanobiotechnology. 22(1). 196–196. 18 indexed citations
10.
Tian, Meng, et al.. (2024). The role of ferroptosis resistance in lymph-associated tumour metastasis. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1879(6). 189200–189200. 2 indexed citations
11.
Yu, Liuchunyang, Xiaoxia Xue, Xiangpeng Wang, et al.. (2024). Application of galactosylated albumin for targeted delivery of triptolide to suppress hepatocellular carcinoma progression through inhibiting de novo lipogenesis. Biomedicine & Pharmacotherapy. 179. 117432–117432. 5 indexed citations
12.
Wang, Xiangpeng, Yurong Song, Liuchunyang Yu, et al.. (2023). Co-Delivery of Hesperetin and Cisplatin via Hyaluronic Acid-Modified Liposome for Targeted Inhibition of Aggression and Metastasis of Triple-Negative Breast Cancer. ACS Applied Materials & Interfaces. 15(29). 34360–34377. 35 indexed citations
13.
Zhang, Zhengjia, Liuchunyang Yu, Yang Li, et al.. (2022). The Role of miRNA in Tumor Immune Escape and miRNA-Based Therapeutic Strategies. Frontiers in Immunology. 12. 807895–807895. 60 indexed citations
14.
Hua, Zhenglai, Xinyi Luo, Yang Li, et al.. (2022). Application and pharmacological mechanism of methotrexate in rheumatoid arthritis. Biomedicine & Pharmacotherapy. 150. 113074–113074. 79 indexed citations
15.
Song, Yurong, Chenxi Li, Zhengjia Zhang, et al.. (2022). The naturally occurring flavonoid nobiletin reverses methotrexate resistance via inhibition of P-glycoprotein synthesis. Journal of Biological Chemistry. 298(4). 101756–101756. 11 indexed citations
16.
Li, Chenxi, Yurong Song, Youwen Chen, et al.. (2022). Hyaluronic Acid Hydrogels Hybridized With Au-Triptolide Nanoparticles for Intraarticular Targeted Multi-Therapy of Rheumatoid Arthritis. Frontiers in Pharmacology. 13. 849101–849101. 17 indexed citations
17.
Li, Wen, Zhiwen Cao, Liuchunyang Yu, et al.. (2021). Hierarchical drug release designed Au @PDA-PEG-MTX NPs for targeted delivery to breast cancer with combined photothermal-chemotherapy. Journal of Nanobiotechnology. 19(1). 143–143. 27 indexed citations
18.
Liu, Guangzhi, Yurong Song, Chenxi Li, et al.. (2021). Arsenic compounds: The wide application and mechanisms applied in acute promyelocytic leukemia and carcinogenic toxicology. European Journal of Medicinal Chemistry. 221. 113519–113519. 20 indexed citations
19.
Yu, Liuchunyang, Zhenglai Hua, Xinyi Luo, Ting Zhao, & Yuanyan Liu. (2021). Systematic interaction of plasma albumin with the efficacy of chemotherapeutic drugs. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1877(1). 188655–188655. 28 indexed citations
20.
Chen, Youwen, Rui Liu, Chenxi Li, et al.. (2021). Nab-paclitaxel promotes the cancer-immunity cycle as a potential immunomodulator.. American Journal of Cancer Research. 11(7). 3445–3460. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jinhai Tang Breakdown of academic impact, for papers by Jingjing Gong Breakdown of academic impact, for papers by Yi‐An Cheng Breakdown of academic impact, for papers by Fatemeh Rezaei‐Tazangi Breakdown of academic impact, for papers by Małgorzata Krawczyk Breakdown of academic impact, for papers by Shibo Ying Breakdown of academic impact, for papers by Jiagang Liu Breakdown of academic impact, for papers by Heng Zheng Breakdown of academic impact, for papers by Ying Shen Breakdown of academic impact, for papers by Dawei Li
Rankless by CCL
2026